LogoFresh Jobs Ahead
Janux Therapeutics
Janux Therapeutics
51 – 200 Zaposleni
BiotehnologijaZdravstveno varstvoZdravstveno zavarovanje
Janux Therapeutics is a biotechnology company developing tumor-activated immunotherapies for cancer treatment. Its research centers on precision-engineered bispecific molecules intended to activate immune responses within the tumor microenvironment, helping direct T cells toward cancer cells while limiting activity elsewhere. The company is advancing clinical development of its lead program, JANX007, for prostate cancer.
LinkedIn
Delovna mesta v podjetju

Vice President, Investor Relations & Corporate Communications - Janux Therapeutics

Lead investor relations and corporate communications at Janux Therapeutics, a biotechnology company. Shape investor engagement, market positioning, and public-company messaging around scientific and financial milestones.

USZdružene države AmerikeCAKalifornija
317.000 $ – 347.000 $ / leto
HibridnoPolni delovni časVodjaZahtevani Jezik: angleščinaPodpredsednik

Opis

  • Create and deliver an investor relations and corporate communications strategy that supports Janux’s mission, pipeline, business goals, and long-term value creation
  • Define Janux’s corporate narrative, brand positioning, identity, and messaging architecture
  • Develop relationships with institutional investors, analysts, and banking partners
  • Direct investor engagement and targeting through conferences, non-deal roadshows, R&D and Analyst Days, KOL webinars, analyst meetings, and related events
  • Design and implement shareholder targeting and ownership strategies
  • Prepare senior leaders for investor conferences, non-deal roadshows, and other high-profile investor engagements
  • Develop core messages, FAQs, Q&A materials, briefings, and response frameworks
  • Oversee earnings materials, investor presentations, scripts, press releases, website copy, talking points, and executive briefing materials
  • Plan communications for clinical and regulatory milestones, transactions, partnerships, and financing activities
  • Maintain an integrated communications calendar and agenda
  • Represent Janux externally to the investment community and media
  • Assess investor sentiment, stock performance, analyst coverage and commentary, peer results, and capital-markets trends
  • Monitor sell-side models against internal forecasts
  • Work with Legal and Finance on public communications, disclosures, earnings materials, SEC reporting, Reg FD compliance, and material-event communications
  • Deliver strategic analysis and recommendations to executive leadership and the Board
  • Collaborate with Clinical, Project Management, Regulatory, HR, Finance, and Legal teams
  • Manage external investor-relations and communications agencies and consultants, including scope, budgets, performance, and measurement
  • Report to the Chief Corporate and Business Development Officer
  • Counsel executive leadership and the Board on investor sentiment, shareholder communications, market positioning, and reputational risk
  • Handle additional responsibilities as required

Zahteve

  • Bachelor’s degree in Finance, Biology, Communications, or a related discipline is required; an MBA, PhD, or MS is preferred
  • At least 12–15 years of progressive leadership experience in investor relations and/or corporate communications within biotechnology, pharmaceuticals, or life sciences
  • Extensive experience leading teams and programs
  • Significant oncology experience is required
  • Track record supporting innovative therapeutic platforms and complex modalities, including T-cell engagers, bispecific antibodies, CAR-T or other cell therapies, antibody-drug conjugates, or advanced biologics
  • Autoimmune experience is strongly preferred
  • Outstanding communication skills, with the ability to explain complex scientific and business developments through clear, persuasive narratives
  • Strong command of capital markets, investor behavior, and biotechnology valuation factors
  • Thorough knowledge of SEC rules, Reg FD, disclosure requirements, corporate governance, and investor-relations practices
  • Established connections with healthcare and life-sciences investors, analysts, and media
  • Experience with investor-relations and communications platforms, external-agency management, budgets, and performance measurement
  • Comfort working in a fast-moving, science-led organization
  • Ability to influence cross-functional teams and senior stakeholders, demonstrate executive presence, and advise senior leaders
  • Experience establishing or substantially advancing investor-relations and corporate-communications functions, infrastructure, and practices
  • Experience guiding publicly traded biotechnology companies through major clinical, regulatory, corporate-development, and financing milestones
  • Excellent writing and editorial judgment for scientific, corporate, investor, media, and employee audiences
  • Strong integrity and dedication to ethical conduct
  • Authorization to work in the United States is required

Ugodnosti

  • Annual bonus opportunity
  • Incentive stock option program
  • 401(k) plan with a flat, non-elective employer contribution
  • Comprehensive medical coverage with 90–100% of premiums paid by the employer
  • Dental and vision coverage
  • HSA, FSA, and supplemental life, disability, accident, critical-illness, and hospital-indemnity insurance
  • Unlimited paid time off
  • Generous holiday calendar with summer and winter company shutdowns
  • Relocation support
  • Stock options
  • Restricted stock units
  • Employee stock purchase plan
  • Target bonus
  • Remote work available with approval
  • Travel of up to 25% for meetings or site visits

Sorodna delovna mesta

General Dynamics Ordnance and Tactical Systems

Senior Financial Analyst, SRM

General Dynamics Ordnance and Tactical Systems
1001 – 5000 Zaposleni
Letalska in vesoljska industrijaObrambaProizvodnja
USZdružene države AmerikeALAlabamaFLFlorida
95.000 $ – 120.000 $ / leto
HibridnoPolni delovni časSeniorZahtevani Jezik: angleščinaFinančno načrtovanje in analiza

Oversee budgets, forecasts, and financial performance for General Dynamics Ordnance and Tactical Systems programs. Support operational decisions, compliance, audits, and profitability.

Odpri